Literature DB >> 17554583

Cell proliferation and oxygen diffusion in a vascularising scaffold.

Kerry A Landman1, Anna Q Cai.   

Abstract

The supply of oxygen to proliferating cells within a scaffold is a key factor for the successful building of new tissue in soft tissue engineering applications. A recent in vivo model, where an arteriovenous loop is placed in a scaffold, allows a vascularising network to form within a scaffold, establishing an oxygen source within, rather than external, to the scaffold. A one-dimensional model of oxygen concentration, cell proliferation and cell migration inside such a vascularising scaffold is developed and investigated. In addition, a vascularisation model is presented, which supports a vascularisation front which moves at a constant speed. The effects of vascular growth, homogenous and heterogenous seeding, diffusion of cells and critical hypoxic oxygen concentration are considered. For homogenous seeding, a relationship between the speed of the vascular front and a parameter defining the rate of oxygen diffusion relative to the rate of oxygen consumption determines whether a hypoxic region exists at some time. In particular, an estimate of the length of time that a fixed point in the scaffold will remain under hypoxic conditions is determined. For heterogenous seeding, a Fisher-like travelling wave of cells is established behind the vascular front. These findings provide a fundamental understanding of the important interplay between the parameters and allows for a theoretical assessment of a seeding strategy in a vascularising scaffold.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554583     DOI: 10.1007/s11538-007-9225-x

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  10 in total

Review 1.  Vascularized bone tissue engineering: approaches for potential improvement.

Authors:  Lonnissa H Nguyen; Nasim Annabi; Mehdi Nikkhah; Hojae Bae; Loïc Binan; Sangwon Park; Yunqing Kang; Yunzhi Yang; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2012-09-04       Impact factor: 6.389

2.  Producing organs in the laboratory.

Authors:  Mark E Furth; Anthony Atala
Journal:  Curr Urol Rep       Date:  2008-11       Impact factor: 3.092

3.  An approach to architecture 3D scaffold with interconnective microchannel networks inducing angiogenesis for tissue engineering.

Authors:  Jiaoxia Sun; Yuanliang Wang; Zhiyong Qian; Chenbo Hu
Journal:  J Mater Sci Mater Med       Date:  2011-08-23       Impact factor: 3.896

Review 4.  Endothelialized biomaterials for tissue engineering applications in vivo.

Authors:  Omar F Khan; Michael V Sefton
Journal:  Trends Biotechnol       Date:  2011-05-05       Impact factor: 19.536

5.  Oxygen-tension controlled matrices for enhanced osteogenic cell survival and performance.

Authors:  A R Amini; S P Nukavarapu
Journal:  Ann Biomed Eng       Date:  2014-02-26       Impact factor: 3.934

6.  Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering.

Authors:  Erin L Pardue; Samir Ibrahim; Anand Ramamurthi
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

7.  Tissue engineering: current strategies and future directions.

Authors:  Jennifer L Olson; Anthony Atala; James J Yoo
Journal:  Chonnam Med J       Date:  2011-04-26

8.  Optimising cell aggregate expansion in a perfused hollow fibre bioreactor via mathematical modelling.

Authors:  Lloyd A C Chapman; Rebecca J Shipley; Jonathan P Whiteley; Marianne J Ellis; Helen M Byrne; Sarah L Waters
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

9.  A Continuum Mathematical Model of Substrate-Mediated Tissue Growth.

Authors:  Maud El-Hachem; Scott W McCue; Matthew J Simpson
Journal:  Bull Math Biol       Date:  2022-03-02       Impact factor: 1.758

10.  Irregular Bone Defect Repair Using Tissue-Engineered Periosteum in a Rabbit Model.

Authors:  Lin Zhao; Junli Zhao; Jia-Jia Yu; Cangyu Zhang
Journal:  Tissue Eng Regen Med       Date:  2020-09-10       Impact factor: 4.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.